142 related articles for article (PubMed ID: 11306392)
21. Long-term clinical outcome of diagnostic transurethral resection of the prostate in patients with elevated prostate-specific antigen level and minor lower urinary tract symptoms.
van Renterghem K; van Koeveringe G; Achten R; van Kerrebroeck P
Urol Int; 2009; 83(1):60-5. PubMed ID: 19641361
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men.
Catalona WJ; Richie JP; Ahmann FR; Hudson MA; Scardino PT; Flanigan RC; DeKernion JB; Ratliff TL; Kavoussi LR; Dalkin BL; Waters WB; MacFarlane MT; Southwick PC
J Urol; 2017 Feb; 197(2S):S200-S207. PubMed ID: 28012755
[TBL] [Abstract][Full Text] [Related]
23. Prostate cancer screening in Tyrol, Austria: experience and results.
Horninger W; Reissigl A; Rogatsch H; Volgger H; Studen M; Klocker H; Bartsch G
Eur Urol; 1999; 35(5-6):523-38. PubMed ID: 10325519
[TBL] [Abstract][Full Text] [Related]
24. Could the sextant prostate biopsy be replaced by transurethral resection?
Startsev VY; Pouline I; Gorelov S; Merkulova R
Arch Ital Urol Androl; 2005 Dec; 77(4):194-8. PubMed ID: 16444931
[TBL] [Abstract][Full Text] [Related]
25. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
Dell'Atti L
J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic role of prostate resection in the elderly patients who experience significant co-morbidity with a high clinical suspicion of prostate cancer.
Kang HW; Yang JB; Kwon WA; Lee YS; Kim WT; Kim YJ; Yun SJ; Lee SC; Kim IY; Kim WJ
J Korean Med Sci; 2013 Dec; 28(12):1796-800. PubMed ID: 24339711
[TBL] [Abstract][Full Text] [Related]
27. Prostate-specific antigen and early detection of prostate cancer.
Chu TM
Tumour Biol; 1997; 18(2):123-34. PubMed ID: 9222310
[TBL] [Abstract][Full Text] [Related]
28. Optimizing prostate cancer screening; prospective randomized controlled study of the role of PSA and PCA3 testing in a sequential manner in an opportunistic screening program.
Rubio-Briones J; Casanova J; Dumont R; Rubio L; Fernandez-Serra A; Casanova-Salas I; Domínguez-Escrig J; Ramírez-Backhaus M; Collado A; Gómez-Ferrer A; Iborra I; Monrós JL; Ricós JV; Solsona E; Salas D; Martínez F; Lopez-Guerrero JA
Actas Urol Esp; 2014 May; 38(4):217-23. PubMed ID: 24169211
[TBL] [Abstract][Full Text] [Related]
29. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
Faria EF; Carvalhal GF; dos Reis RB; Tobias-Machado M; Vieira RA; Reis LO; Nogueira L; Machado RD; Freitas CH; Magnabosco WJ; Mauad EC; Carvalho AL
BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057
[TBL] [Abstract][Full Text] [Related]
30. Delays in cancer detection using 2 and 4-year screening intervals for prostate cancer screening with initial prostate specific antigen less than 2 ng/ml.
Kundu SD; Grubb RL; Roehl KA; Antenor JA; Han M; Catalona WJ
J Urol; 2005 Apr; 173(4):1116-20. PubMed ID: 15758718
[TBL] [Abstract][Full Text] [Related]
31. Prostate cancer detection by TURP after repeated negative saturation biopsy in patients with persistent suspicion of cancer: a case-control study on 75 consecutive patients.
Pepe P; Fraggetta F; Galia A; Grasso G; Aragona F
Prostate Cancer Prostatic Dis; 2010 Mar; 13(1):83-6. PubMed ID: 19901959
[TBL] [Abstract][Full Text] [Related]
32. Value of various PSA parameters for diagnosing prostate cancer in men with normal digital rectal examination.
Miotto A; Srougi M; Brito GA; Leite KM; Nesrallah AJ; Ortiz V
Int Braz J Urol; 2004; 30(2):109-13. PubMed ID: 15703091
[TBL] [Abstract][Full Text] [Related]
33. Tumor cytoreduction results in better response to androgen ablation--a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancer.
Qin XJ; Ma CG; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ; Zhu Y; Zhu YP; Shi GH; Xiao WJ; Lin GW; Swanson GP
Urol Oncol; 2012; 30(2):145-9. PubMed ID: 20451424
[TBL] [Abstract][Full Text] [Related]
34. Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial.
Yli-Hemminki TH; Laurila M; Auvinen A; Määttänen L; Huhtala H; Tammela TL; Kujala PM
BJU Int; 2013 Oct; 112(6):735-41. PubMed ID: 23746332
[TBL] [Abstract][Full Text] [Related]
35. Clinical relevance of transurethral resection of the prostate in "asymptomatic" patients with an elevated prostate-specific antigen level.
van Renterghem K; Van Koeveringe G; Achten R; Van Kerrebroeck P
Eur Urol; 2007 Sep; 52(3):819-26. PubMed ID: 17418482
[TBL] [Abstract][Full Text] [Related]
36. Is prostate-specific antigen velocity selective for clinically significant prostate cancer in screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam).
Wolters T; Roobol MJ; Bangma CH; Schröder FH
Eur Urol; 2009 Feb; 55(2):385-92. PubMed ID: 18353529
[TBL] [Abstract][Full Text] [Related]
37. [Mass screening for prostate cancer at Ikeda City in Osaka Prefecture--results of screening with PSA alone between 2003 and 2007].
Inoue H; Kinouchi T; Kinoshita T; Kobayashi M; Ued T; Takada T; Hara T; Yamaguchi S; Kajimoto M; Kitamura K
Nihon Hinyokika Gakkai Zasshi; 2010 Jul; 101(5):671-5. PubMed ID: 20715498
[TBL] [Abstract][Full Text] [Related]
38. TP53 mutation in prostate needle biopsies--comparison with patients follow-up.
Ecke TH; Schlechte HH; Hübsch A; Lenk SV; Schiemenz K; Rudolph BD; Miller K
Anticancer Res; 2007; 27(6B):4143-8. PubMed ID: 18225585
[TBL] [Abstract][Full Text] [Related]
39. [A case of ductal carcinoma of the prostate after transurethral resection of prostate].
Izumi K; Kanno H; Umemoto S; Hasumi H; Osada Y; Ota J; Tsuchiya F; Ogino I; Harada M
Hinyokika Kiyo; 2007 May; 53(5):315-8. PubMed ID: 17561717
[TBL] [Abstract][Full Text] [Related]
40. [Rates of prostate-specific antigen testing for early detection of prostate cancer: a first comparison of German results with current international data].
Lebentrau S; May M; Maurer O; Schostak M; Lehsnau M; Ecke T; Al-Dumaini S; Hallmann S; Ahmed AM; Braun V; Haferkamp A; Bauer RM; Stief CG; Baumunk D; Hoschke B; Braun HP; Schäfer C; Hipp M; Maurer J; Braun KP; Wolff I; Brookman-May S; Gilfrich C
Urologe A; 2014 May; 53(5):715-24. PubMed ID: 24700162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
